These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 26687717)

  • 41. A novel restriction-modification system from Xanthomonas campestris pv. vesicatoria encodes a m4C-methyltransferase and a nonfunctional restriction endonuclease.
    Yu YJ; Yang MT
    FEMS Microbiol Lett; 2007 Jul; 272(1):83-90. PubMed ID: 17488332
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Two different restriction-modification systems for degrading exogenous DNA in Paenibacillus polymyxa.
    Shen M; Chen Z; Mao X; Wang L; Liang J; Huo Q; Yin X; Qiu J; Sun D
    Biochem Biophys Res Commun; 2018 Oct; 504(4):927-932. PubMed ID: 30224061
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of the archaeal, plasmid-encoded type II restriction-modification system MthTI from Methanobacterium thermoformicicum THF: homology to the bacterial NgoPII system from Neisseria gonorrhoeae.
    Nölling J; de Vos WM
    J Bacteriol; 1992 Sep; 174(17):5719-26. PubMed ID: 1512204
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo DNA protection by relaxed-specificity SinI DNA methyltransferase variants.
    Tímár E; Venetianer P; Kiss A
    J Bacteriol; 2008 Dec; 190(24):8003-8. PubMed ID: 18849437
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DNA methylases for site-selective inhibition of type IIS restriction enzyme activity.
    Flores-Fernández CN; Lin D; Robins K; O'Callaghan CA
    Appl Microbiol Biotechnol; 2024 Jan; 108(1):174. PubMed ID: 38270650
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Avoidance of recognition sites of restriction-modification systems is a widespread but not universal anti-restriction strategy of prokaryotic viruses.
    Rusinov IS; Ershova AS; Karyagina AS; Spirin SA; Alexeevski AV
    BMC Genomics; 2018 Dec; 19(1):885. PubMed ID: 30526500
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bacterial Autoimmunity Due to a Restriction-Modification System.
    Pleška M; Qian L; Okura R; Bergmiller T; Wakamoto Y; Kussell E; Guet CC
    Curr Biol; 2016 Feb; 26(3):404-9. PubMed ID: 26804559
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of a restriction modification system from the commensal Escherichia coli strain A0 34/86 (O83:K24:H31).
    Weiserová M; Ryu J
    BMC Microbiol; 2008 Jun; 8():106. PubMed ID: 18588664
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selfish behavior of restriction-modification systems.
    Naito T; Kusano K; Kobayashi I
    Science; 1995 Feb; 267(5199):897-9. PubMed ID: 7846533
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Isolation of a non-classical mutant of the DNA recognition subunit of the type I restriction endonuclease R.EcoR124I.
    Weiserova M; Firman K
    Biol Chem; 1998; 379(4-5):585-9. PubMed ID: 9628361
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic diversity of the HpyC1I restriction modification system in Helicobacter pylori.
    Lehours P; Dupouy S; Chaineux J; Ruskoné-Fourmestraux A; Delchier JC; Morgner A; Mégraud F; Ménard A
    Res Microbiol; 2007 Apr; 158(3):265-71. PubMed ID: 17346936
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of Restriction-Modification Systems in Prokaryotic Evolution and Ecology.
    Ershova AS; Rusinov IS; Spirin SA; Karyagina AS; Alexeevski AV
    Biochemistry (Mosc); 2015 Oct; 80(10):1373-86. PubMed ID: 26567582
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Antirestriction proteins ardA and Ocr as effective inhibitors of the type I restriction-modification enzymes].
    Zavil'gel'skiĭ GB; Rastorguev SM
    Mol Biol (Mosk); 2009; 43(2):264-73. PubMed ID: 19425495
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Restriction-modification systems as genomic parasites in competition for specific sequences.
    Kusano K; Naito T; Handa N; Kobayashi I
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):11095-9. PubMed ID: 7479944
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tuning the relative affinities for activating and repressing operators of a temporally regulated restriction-modification system.
    Mruk I; Blumenthal RM
    Nucleic Acids Res; 2009 Feb; 37(3):983-98. PubMed ID: 19126580
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Restriction-modification systems and bacteriophage invasion: who wins?
    Enikeeva FN; Severinov KV; Gelfand MS
    J Theor Biol; 2010 Oct; 266(4):550-9. PubMed ID: 20633563
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transcription regulation of restriction-modification system Esp1396I.
    Bogdanova E; Zakharova M; Streeter S; Taylor JEN; Heyduk T; Kneale G; Severinov K
    Nucleic Acids Res; 2009 Jun; 37(10):3354-66. PubMed ID: 19336410
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transcription regulation of the EcoRV restriction-modification system.
    Semenova E; Minakhin L; Bogdanova E; Nagornykh M; Vasilov A; Heyduk T; Solonin A; Zakharova M; Severinov K
    Nucleic Acids Res; 2005; 33(21):6942-51. PubMed ID: 16332697
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure of the restriction-modification controller protein C.Esp1396I.
    Ball N; Streeter SD; Kneale GG; McGeehan JE
    Acta Crystallogr D Biol Crystallogr; 2009 Sep; 65(Pt 9):900-5. PubMed ID: 19690367
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A genetic dissection of the LlaJI restriction cassette reveals insights on a novel bacteriophage resistance system.
    O'Driscoll J; Heiter DF; Wilson GG; Fitzgerald GF; Roberts R; van Sinderen D
    BMC Microbiol; 2006 Apr; 6():40. PubMed ID: 16646963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.